BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marks KE, Flaherty S, Patterson KM, Stratton M, Martinez GJ, Reynolds JM. Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for IPCEF in regulating Th17 cell migration. Cell Rep 2021;35:109303. [PMID: 34192530 DOI: 10.1016/j.celrep.2021.109303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee HJ, Hoe HS. Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling. Pharmacol Res 2023;:106725. [PMID: 36907286 DOI: 10.1016/j.phrs.2023.106725] [Reference Citation Analysis]
2 Kurago Z, Loveless J. Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma. Front Oral Health 2021;2:739499. [PMID: 35048056 DOI: 10.3389/froh.2021.739499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tian Y, Huang B, Li J, Tian X, Zeng X. Identification of the Association Between Toll-Like Receptors and T-Cell Activation in Takayasu’s Arteritis. Front Immunol 2022;12:792901. [DOI: 10.3389/fimmu.2021.792901] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Marks KE, Cho K, Stickling C, Reynolds JM. Toll-like Receptor 2 in Autoimmune Inflammation. Immune Netw 2021;21:e18. [PMID: 34277108 DOI: 10.4110/in.2021.21.e18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]